Short answer: CJC-1295 and ipamorelin are the most popular growth-hormone-pathway pairing in the peptide world, and the logic is well documented: each signals the pituitary through a different receptor. Human pharmacology research exists for CJC-1295, and users commonly report better recovery and workout support
[attributed user reports].
This is the reference page for the pair: where each molecule came from, how the mechanism works, what the research has explored, how formats differ, and where the pair lives in our catalog. For real-world use, see how the CJC-1295 + ipamorelin stack is used.
Where the pair came from
CJC-1295 was developed by ConjuChem Biotechnologies as a long-acting analog of growth hormone–releasing hormone (GHRH) — the body's own "release growth hormone now" signal. Native GHRH vanishes in minutes, so ConjuChem engineered a version built to last.
Ipamorelin came out of Novo Nordisk's labs in the 1990s. In its 1998 characterization study (Raun et al., European Journal of Endocrinology, PMID 9849822), it stood out from earlier secretagogues for one elegant reason: it prompted growth hormone release selectively, without the cortisol and ACTH spillover its predecessors produced — even at doses 200-fold above the GH-releasing dose [preclinical evidence]. That clean profile is why ipamorelin became the default partner peptide.
How the pair is thought to work
Think of the pituitary as a soundboard with two faders. CJC-1295 rides the GHRH fader — the "how much" signal. Ipamorelin rides the ghrelin-receptor (GHS-R1a) fader — the "when" signal. Two peptides, one target, two complementary pathways: that's the whole logic of the pairing, and it's a coherent piece of receptor pharmacology, not marketing math [published human data — class level, not this pair].
One nuance worth knowing: CJC-1295 exists in two forms. The DAC form binds albumin and lasts for days (half-life 5.8–8.1 days in human studies); the no-DAC form (often called Mod GRF 1-29) is short-acting and sharper. The human trial data belongs to the DAC form. The InstaMed Strength panel states "CJC-1295 250 mcg" without specifying — a fair question to ask any vendor, including us.
What the research has explored
The encouraging core, honestly tagged:
- In two randomized, double-blind, placebo-controlled trials in healthy adults 21–61 (Teichman et al., J Clin Endocrinol Metab, 2006; PMID 16352683), a single injection of CJC-1295 (DAC form) produced dose-dependent 2- to 10-fold GH increases lasting 6+ days and 1.5- to 3-fold IGF-I increases lasting 9–11 days, with no serious adverse reactions reported
[published human data — injectable DAC form only]. - A companion study (Ionescu & Frohman, JCEM 2006, PMID 17018654) found the body's natural GH pulsatility was preserved — the sustained elevation didn't flatten the rhythm
[published human data — injectable DAC form only]. - Ipamorelin's selectivity is characterized across rat pituitary cells, rats, and swine (Raun et al., 1998), plus early human pharmacokinetic modeling (Gobburu et al., Pharmaceutical Research, 1999)
[published human data — PK only].
What users commonly report in this category: easier recovery between training sessions, a deeper sense of rest, and steady energy [attributed user reports — unquantified]. Brand-side descriptions of the Strength strip use structure/function language like "supports your body's natural growth hormone pathways" [brand claim — unverified].
The regulatory story is moving in an interesting direction: after time on FDA's Category-2 watch list, the CJC-1295 nominations were withdrawn, and FDA's advisory committees formally reviewed the secretagogue class in late 2024 — the rules in this space are actively being re-examined. One hard note: GH secretagogues sit on the WADA Prohibited List (S2), so drug-tested athletes should sit this pair out.
The honest context
Here is the passage that doesn't help us sell, and we'd rather say it than have you find it elsewhere. No published human trial has tested CJC-1295 + ipamorelin as a fixed pair for any outcome — the human data is component-level, injectable, and measured hormone levels rather than muscle, fat, or sleep outcomes. And no published study has tested either peptide sublingually: what absorbs from a strip is unmeasured, which we cover plainly on the sublingual delivery science page. If you have a genuine clinical concern about growth hormone, the right move is a physician and lab work, not a secretagogue in any format. Adults 18+ only; never while pregnant or nursing; talk to a licensed provider first.
Formats: injection legacy, strip present
The research record is injectable; the modern consumer format is the strip. A dissolving strip means no needles, no mixing, no refrigeration ritual — it goes in your gym bag and dissolves in about a minute. The format is newer than the research, and we say so — but as a daily-experience upgrade over the vial-and-syringe world, users find it dramatically easier to stay consistent [attributed user reports].
Where the pair appears in our catalog
There is no standalone CJC-1295 product — here or in most of the market. The pair is the product:
- Strength — CJC-1295 / Ipamorelin sublingual strips: CJC-1295 250 mcg + ipamorelin 250 mcg per strip, 20 strips per box, citrus, per the printed Supplement Facts panel. Strength is openly stocked at $145 per 20-strip box.
The strips are sold under the InstaMed brand (Salt Lake City/Draper, Utah); we sell them as an authorized reseller. Per our safety and sourcing standards, ask any supplier — including us — for a lot-specific Certificate of Analysis.
The bottom line
CJC-1295 + ipamorelin is a smartly designed pair with a real mechanism story, human pharmacology behind its anchor compound, and a devoted following among recovery-minded users. In the Strength strip, you get both in one citrus strip with a clean, readable panel — 250 mcg + 250 mcg, 20 strips — no needles required. If the growth-hormone-pathway category is the one you're curious about, this is the most sensible, best-characterized place to start.
---
Explore this cluster
The rest of the CJC-1295 and ipamorelin file: what each peptide does on its own, how they compare to the alternatives, and how the strip is used.
- How to Use CJC-1295: What Labels and Clinics Say (and What We Won't Tell You)
- How to Use Ipamorelin Strips: The Simple Daily Routine, Explained
- CJC-1295 Benefits: What the Injectable Research Shows (and What It Doesn't Prove for Strips)
- CJC-1295 vs Sermorelin: The Secretagogue Comparison, Honestly
- Ipamorelin Benefits: The Selectivity Story, Told Properly
- Sermorelin vs Ipamorelin: Two Different Answers to the Same Signal
- Ipamorelin Side Effects and Safety: What Users and Studies Report
- Does Sublingual Ipamorelin Work?
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.